Week 3 Endocrinology Drugs Part 1 Flashcards

(74 cards)

1
Q

generic for Novolog

A

insulin aspart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

generic for Humalog

A

insulin lispro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

generic for Levemir

A

insulin detemir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

generic for Lantus, Basaglar

A

insulin glargine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

generic for Glucophage

A

metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

generic for Actos

A

pioglitazone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

generic for Trulicity

A

dulaglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

generic for Victoza

A

liraglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

generic for Ozempic, Rybelsus, Wedovy

A

semaglutide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

generic for Amaryl

A

glimepiride

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

generic for Glucotrol

A

glipizide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

generic for Januvia

A

sitagliptan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

generic for Jardiance

A

empagliflozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

pharmacologic class for insulin aspart

A

insulin; rapid acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

FDA indication(s) for insulin aspart

A

Type I Diabetes, Type II Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

adverse effects of insulin aspart

A

Severe hypoglycemia, injection site reactions, rash, pruritis, headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

monitoring for insulin aspart

A

Blood sugar levels, A1C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

pharmacologic class for insulin lispro

A

insulin; rapid acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

FDA indication(s) for insulin lispro

A

Type I Diabetes, Type II Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

adverse effects of insulin lispro

A

Severe hypoglycemia, injection site reactions, rash, pruritis, headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

monitoring for insulin lispro

A

Blood sugar levels, A1C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

pharmacologic class for insulin detemir

A

insulin; long acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

FDA indication(s) for insulin detemir

A

Type I Diabetes, Type II Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

adverse effects of insulin detemir

A

Severe hypoglycemia, injection site reactions, rash, pruritis, headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
monitoring for insulin detemir
Blood sugar levels, A1C
26
pharmacologic drug class for metformin
Biguanide
27
FDA indication(s) for metformin
Type II Diabetes
28
contraindication(s) for metformin
Severe reneal impairment (eGFR <30 mL/min), Metabolic acidosis
29
black box warning for metformin
Lactic acidosis. Risk increases with renl impairment and with radiological studies with contrast.
30
adverse effects of metformin
Diarrhea, flatulence, nausea/vomiting, metallic taste, lactic acidosis
31
monitoring for metformin
A1C, Renal function
32
pharmacologic drug class for pioglitazone
Thiazolidinedione
33
FDA indication(s) for pioglitazone
Type II Diabetes
34
contraindication(s) for pioglitazone
heart failure
35
black box warning for pioglitazone
Heart Failure: May cause or worsen heart failure in some patients
36
adverse effects of pioglitazone
Edema, weight gain, headache
37
monitoring for pioglitazone
A1C
38
pharmacologic drug class for Trulicity (dulaglutide)
Glucagon-like Peptide 1 (GLP-1) Agonist
39
FDA indication(s) for Trulicity
Type II Diabetes
40
contraindication(s) for Trulicity
Personal or Family History of Medullary Thyroid Carcinoma
41
black box warning for Trulicity
Thyroid C-cell tumors
42
adverse effects of Trulicity
Headache, nausea/vomiting, diarrhea, decreased appetite, fatigue, dizziness, injection site reactions
43
monitoring for Trulicity
A1C
44
pharmacologic drug class for Victoza (liraglutide)
Glucagon-like Peptide 1 (GLP-1) Agonist
45
FDA indication(s) for Victoza
Type II Diabetes, Obesity
46
contraindication(s) for Victoza
Pregancy, Personal or Family History of Medullary Thyroid Carcinoma
47
black box warning for Victoza
Thyroid C-cell tumors
48
adverse effects of Victoza
Headache, nausea/vomiting, diarrhea, decreased appetite, fatigue, dizziness, injection site reactions
49
monitoring for Victoza
A1C
50
pharmacologic drug class for Ozempic, Rybelsus, Wegovy (semaglutide)
Glucagon-like Peptide 1 (GLP-1) Agonist
51
FDA indication(s) for Ozempic, Rybelsus, Wegovy
Type II Diabetes, Obesity
52
contraindication(s) for Ozempic, Rybelsus, Wegovy
Personal or Family History of Medullary Thyroid Carcinoma
53
black box warning for Ozempic, Rybelsus, Wegovy
Thyroid C-cell tumors
54
adverse effects of Ozempic, Rybelsus, Wegovy
Headache, nausea/vomiting, diarrhea, decreased appetite, fatigue, dizziness, injection site reactions
55
monitoring for Ozempic, Rybelsus, Wegovy
A1C
56
pharmacologic drug class for glimepiride
Sulfonylurea
57
FDA indication(s) for glimepiride
Type II Diabetes
58
contraindication(s) for glimepiride
Allergy to sulfonamides, Diabetic ketoacidosis
59
adverse effected of glimepride
Hypoglycemia, weight gain, dizziness, diarrhea, nausea, headache
60
monitoring for glimepiride
A1C
61
pharmacologic drug class for glipizide
Sulfonylurea
62
FDA indication(s) for glipizide
Type II Diabetes
63
contraindication(s) for glipizide
Allergy to sulfonamides, Diabetic ketoacidosis
64
adverse effects of glipizide
Hypoglycemia, weight gain, dizziness, diarrhea, nausea, headache
65
monitoring for glipizide
A1C
66
pharmacologic drug class for Januvia (sitagliptan)
Dipeptidyl Peptidase IV (DPP-IV) Inhibitor
67
FDA indication(s) for Januvia
Type II Diabetes
68
adverse effects of Januvia
Abdominal pain, diarrhea, pharyngitis, headache, peripheral edema, hypoglycemia, pancreatitis
69
monitoring for Januvia
A1C, renal function
70
pharmacologic drug class for Jardiance (empagliflozin)
Sodium Glucose Co-Transporter 2 (SGLT-2) Inhibitor
71
FDA indication(s) for Jardiance
Type II Diabetes, Heart Failure
72
contraindication(s) for Jardiance
Dialysis
73
adverse effects of Jardiance
Increased frequency of urination, urinary tract infections, female genital infections, hypoglycemia
74
monitoring for Jardiance
A1C, Signs of infection